Physician's Weekly1h
Survival Outcomes of HSCT in Advanced Primary Cutaneous Lymphoma
The following is a summary of “Hematopoietic stem cell transplant in cutaneous T-cell lymphomas: A multicentre ...
Nature3y
Raising the bar for blood disease research and treatment
Wu described an allogeneic type of HSCT known as ‘haploidentical ... to form blood clots by clumping together with platelets. TTP episodes, caused by ADAMTS13 deficiency, could range from ...
WebMD1y
Vitamins by Condition
Considering taking supplements to treat hematopoietic stem cell transplant hsct? Below is a list of common natural remedies used to treat or reduce the symptoms of hematopoietic stem cell ...
Seres Therapeutics Receives Feedback From FDA on SER-155 Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT) Development Approach
FDA has provided input on key elements of the SER-155 allo-HSCT clinical development plans including support for the proposed primary efficacy ...
Medscape11y
Pharmacoeconomics of Empirical Antifungal Use in Febrile Neutropenic Hematological Malignancy and Hematopoietic Stem Cell Transplant Patients
Expert Rev Pharmacoeconomics Outcomes Res. 2013;13(2):227-235. †Included absence of a breakthrough fungal infection, survival for 7 days beyond end of therapy, no premature discontinuation of ...
The American Journal of Managed Care19d
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
AlloHeme test accurately predicts relapse post-allo-HSCT in AML and MDS, with a median lead time of 36 days. The ACROBAT study involved 287 patients, showing significant predictive value of ...